MarketsandMarkets: Global Sleep Apnea Devices Market Worth $19.72 Billion by 2017
DALLAS, July 23, 2012 /PRNewswire/ –
The “Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory
Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral
Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landscape
& Forecast to 2017″ report analyzes and studies the major market drivers, restraints, and
opportunities in North America, Europe, Asia, and Rest of the World.
Browse 147 market data tables spread through 318 pages and in-depth TOC of “Sleep
Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs,
Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal
EPAP, Neurostimulation] Global End-user Analysis, Competitive Landscape & Forecast to
Early buyers will receive 10% customization on reports.
This report studies the global sleep apnea devices market, with forecast to 2017.
Sleep problems are touted as a ‘global epidemic’ and sleep apnea is a crucial
contributor to this disorder. Obstructive Sleep Apnea (OSA) is the most common type of
sleep apnea; around 84% of people with sleep apnea are diagnosed with the disease. Studies
suggest that about 100 million people worldwide are suspected to have obstructive sleep
apnea, of which more than 80% remain undiagnosed.
Sleep apnea is a relatively new market in the medical field, gaining momentum at a
fast pace, especially in developed geographies. The demand for sleep apnea devices is
slated to increase at a faster pace, owing to gradually increasing awareness among both
patients and the medical fraternity.
The global sleep apnea devices market was valued at $7.96 billion in the year 2011 and
is expected to reach $19.72 billion by the year 2017. North America was the largest sleep
apnea devices market, followed by Europe and Asia. North America will continue to lead the
sleep apnea device market in the next few years, followed by Europe. The Asian region’s
contribution to the global sleep apnea device market is expected to pick up in the coming
years, as the medical condition gets more recognition.
The global sleep apnea devices market
which is broadly classified into Diagnostic Devices and Therapeutic Devices, is witnessing
high competitive intensity. Segment rivalry is high, as there are a few well-established
firms and several small firms with similar product offerings. The market is dominated by
Philips Respironics and ResMed, Inc., which jointly comprise 70% of the market. Fisher and
Paykel Healthcare, CareFusion Corporation, Natus Medical Incorporated, DeVilbiss
Healthcare, Weinmann Medical Devices, etc. are some of the other prominent players in the
global sleep apnea devices market.
MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotives and transportation, automation and process control,
banking and financial services, biotechnology, chemicals
http://www.marketsandmarkets.com/chemicals-market-research-10.html, consumer goods,
energy and power, food and beverages, industrial automation, medical devices [
pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository. To know more about us and
our reports, please visit our website http://www.marketsandmarkets.com.
Contact: Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: firstname.lastname@example.org MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com http://twitter.com/marketsmarkets